Summary & Overview
HCPCS Level II J0654: Liothyronine Injection, 1 mcg
HCPCS Level II code J0654 identifies an injectable dose of liothyronine at 1 mcg. Liothyronine is a synthetic T3 thyroid hormone used in select clinical scenarios for hormone replacement or diagnostic support. Nationally, accurate coding for parenteral thyroid preparations matters for inventory control, payer adjudication, and clinical documentation when injectable formulations are used instead of oral routes.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coding context, payer coverage themes, and clinical use cases tied to the injectable formulation. The publication outlines common billing considerations for this HCPCS Level II code, typical sites of service where injectable liothyronine is administered (outpatient clinics, physician offices, infusion centers), and where to look for related policy or coverage guidance.
This summary frames what follows: benchmarks for utilization and reimbursement (where available), applicable coding and billing notes, and clinical context for liothyronine injections. Data not available in the input are noted where applicable; the focus remains on national-level implications for coding, billing, and clinical documentation for HCPCS Level II code J0654.
Billing Code Overview
HCPCS Level II code J0654 represents an injection of liothyronine, 1 mcg. This code describes a parenteral formulation of liothyronine administered in microgram dosing for thyroid hormone replacement or diagnostic purposes.
Service Type: Medication administration (injectable)
Typical Site of Service: Outpatient clinic, physician office, or infusion center
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A middle-aged adult with hypothyroidism who requires precise titration of thyroid hormone presents to an outpatient endocrine clinic for medication administration and monitoring. The patient has difficulty with oral levothyroxine absorption due to gastrointestinal issues (e.g., short bowel, malabsorption) or requires short-term inpatient dose adjustment following thyroid surgery. The clinician prescribes liothyronine (synthetic T3) for rapid onset of action. A registered nurse prepares and administers the parenteral J0654 injection (liothyronine, 1 mcg) in a clinic procedure area, ambulatory infusion center, or hospital inpatient unit. The workflow includes medication order verification, informed consent discussion about risks and expected effects, preparation of the correct microgram dose, administration via intramuscular or subcutaneous injection per facility policy, and documentation of lot number, time, site, and patient response. Vital signs and cardiac monitoring may be performed for patients with known cardiac disease or elderly patients due to risk of tachyarrhythmia. The encounter may involve coordination with pharmacy for dosing, and follow-up lab orders for thyroid function tests (TSH, free T4) to guide ongoing therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure |